Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Millbourn E (1950) On the excretory ducts of the pancreas in man, with special reference to their relations to each other, to the common bile duct and to the duodenum: a radiological and anatomical study. Acta Anat 9:1–34
Doubilet H, Mulholland JH (1951) Intubation of the pancreatic duct in the human. Proc Soc Exp Biol Med 76:113–114
Leger L (1953) Surgical contrast visualization of the pancreatic ducts with a study of pancreatic external secretion. Am J Dig Dis 20:8–12
McCune WS, Shorb PE, Moscovitz H (1968) Endoscopic cannulation of the ampulla of Vater. A preliminary report. Ann Surg 167:752–756
Oi I (1970) Fiberduodenoscopy and endoscopic pancreatocholangiography. Gastrointest Endosc 17:59–62
Takagi K, Ikeda S, Nakagawa Y, et al (1970) Retrograde pancreatography and cholangiography by fiber duodenoscope. Gastroenterology 59:445–452
Adamek HE, Albert J, Breer H, et al (2000) Pancreatic cancer detection with magnetic resonance cholangiopancreatography and endoscopic retrograde cholangiopancreatography: a prospective controlled study. Lancet 356:190–193
Glasbrenner B, Kahl S, Malfertheiner P (2002) Modern diagnostics of chronic pancreatitis. Eur J Gastroenterol Hepatol 14:935–941
Hawes RH (2002) Diagnostic and therapeutic uses of ERCP in pancreatic and biliary tract malignancies. Gastrointest Endosc 56:S201–205
Adler DG, Baron TH, Davila RE, et al (2005) ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreas. Gastrointest Endosc 62:1–8
Yamaguchi T, Shirai Y, Ishihara T, et al (2005) Pancreatic juice cytology in the diagnosis of intraductal papillary mucinous neoplasm of the pancreas: significance of sampling by peroral pancreatoscopy. Cancer 104:2630–2636
Glasbrenner B, Kahl S, Malfertheiner P (2002) Modern diagnostics of chronic pancreatitis. Eur J Gastroenterol Hepatol 14:935–941
Cohen S, Bacon BR, Berlin JA, et al (2002) National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14–16, 2002. Gastrointest Endosc 56:803–809
Etenad B, Whitcomb DC (2001) Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology 120:682–707
Nelson DB, Jarvis WR, Rutala WA, et al (2003) Multi-society guideline for reprocessing flexible gastrointestinal endoscopes. Gastrointest Endosc 58:1–8
Rey JF, Bjorkman D, Duforest-Rey D, et al (2005) WGOOMGE practice guideline: endoscope disinfection. http://omge.org/globalguidelines/guide14/g_data14_en.htm 14 Dec
Freeman ML (2002) Adverse outcomes of ERCP. Gastrointest Endosc 56:S278–S282
Vandervoort J, Soetikno RM, Tham TC, et al (2002) Risk factors for complications after performance of ERCP. Gastrointest Endosc 56:652–656
Subhani JM, Kibbler C, Dooley JS (1999) Antibiotic prophylaxis for endoscopic retrograde cholangiopancreatography (ERCP). Aliment Pharmacol Ther 13:103–116
Hirota WK, Petersen K, Baron TH, et al (2003) Guidelines for antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc 58:475–482
Rey JR, Axon A, Budzynska A, et al (1998) Guidelines of the European Society of Gastrointestinal Endoscopy (ESGE): antibiotic prophylaxis for gastrointestinal endoscopy. Endoscopy 30:318–324
Ohto M, Ono T, Tsuchiya Y, Saisho H (1978) Cholangiography and Pancreatography. Igaku-Shoin Tokyo, New York, pp 81–83
Cotton PB (1980) Congenital anomaly of pancreas divisum as cause of obstructive pain and pancreatitis. Gut 21:105–114
Delhaye M, Engelholm L, Cremer M (1985) Pancreas divisum: congenital anatomic variant or anomaly? Contribution of endoscopic retrograde dorsal pancreatography. Gastroenterology 89:951–958
Kalady MF, Peterson B, Baillie J, et al (2004) Pancreatic duct strictures: identifying risk of malignancy. Ann Surg Oncol 11:581–588
Yoshida K, Toki F, Takeuchi T, et al (1995) Chronic Pancreatitis caused by an autoimmune abnormality: proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 40:1561–1568
Pearson RK, Longnecker DS, Chari ST, et al (2003) Controversies in clinical pancreatology: Autoimmune pancreatitis: does it exist? Pancreas 27:1–13
Levy MJ, Wiesema MJ, Chari ST (2006) Chronic pancreatitis: focal pancreatitis or cancer? Is there a role for FNA/biopsy? Autoimmune pancreatitis. Endoscopy 38:530–535
Loperfido S, Angelini G, Benedetti G, et al (1998) Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 48:1–10
Masci E, Toti G, Mariani A, et al (2001) Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol 96:417–423
Mallery JS, Baron TH, Dominitz JA, et al (2003) Complications of ERCP. Gastrointest Endosc 57:633–638
Cotton PB, Lehman G, Vennes J, et al (1991) Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 37:383–393
Freeman ML, Guda NM (2004) Prevention of post-ERCP pancreatitis: a comprehensive review. Gastrointest Endosc 59:845–864
Freeman ML, DiSario JA, Nelson DB, et al (2001) Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc 54:425–434
Cavallini G, Tittobello A, Frulloni L, et al (1996) Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. N Engl J Med 335:919–923
Andriulli A, Leandro G, Niro G, et al (2000) Pharmacologic treatment can prevent pancreatic injury after ERCP: a metaanalysis. Gastrointest Endosc 51:100–103
Arvanitidis D, Anagnostopoulos GK, Giannopoulos D, et al (2004) Can somatostatin prevent post-ERCP pancreatitis? Results of a randomized controlled trial. J Gastroenterol Hepatol 19:278–282
Andriulli A, Solmi L, Loperfido S, et al (2004) Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate. Clin Gastroenterol Hepatol 2:713–718
Andriulli A, Caruso N, Quitadamo M, et al (2003) Antisecretory vs. antiproteasic drugs in the prevention of post-ERCP pancreatitis: the evidence-based medicine derived from a meta-analysis study. JOP 4:41–48
Singh P, Das A, Isenberg G, et al (2004) Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials. Gastrointest Endosc 60:544–550
Fazel A, Quadri A, Catalono MF, et al (2003) Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study. Gastrointest Endosc 57:291–294
Freeman ML, Overby C, Qi D (2004) Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success. Gastrointest Endosc 59:8–14
Harris A, Chan C-H, Torres-Viera C, et al (1999) Metaanalysis of antibiotic prophylaxis in endoscopic retrograde cholangiopancreatography (ERCP) Endoscopy 31:718–724
Nelson DB (2003) Infectious disease complications of GI endoscopy: part II, exogenous infections. Gastrointest Endosc 57:695–711
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Saisho, H. (2008). Endoscopic Retrograde Cholangiopancreatography. In: Beger, H.G., Matsuno, S., Cameron, J.L., Rau, B.M., Sunamura, M., Schulick, R.D. (eds) Diseases of the Pancreas. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-28656-1_9
Download citation
DOI: https://doi.org/10.1007/978-3-540-28656-1_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-28655-4
Online ISBN: 978-3-540-28656-1
eBook Packages: MedicineMedicine (R0)